{
    "clinical_study": {
        "@rank": "100901", 
        "arm_group": [
            {
                "arm_group_label": "VitalStim", 
                "arm_group_type": "Experimental", 
                "description": "This group will be assigned to the active VitalStim unit."
            }, 
            {
                "arm_group_label": "Sham VitalStim", 
                "arm_group_type": "Sham Comparator", 
                "description": "This group will be assigned to the sham VitalStim unit."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate if the use of Neuromuscular Electrical Stimulation\n      (NMES) will provide a more efficient method of treating neonates with dysfunctional oral\n      feeding such as dysphagia.  This study will attempt to determine if NMES applied to neonates\n      at 36-42 weeks post-conception age (PCA) will decrease the need for nasogastric tubes (NG)\n      and gastrostomy tubes (G-TUBE). Increase the rate at which these neonates complete full oral\n      feeds, improve their swallowing skills, increase oral intake of calories, and gain weight."
        }, 
        "brief_title": "Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates", 
        "condition": "Dysphagia", 
        "condition_browse": {
            "mesh_term": "Deglutition Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female.\n\n          -  Meet diagnostic criteria for dysphagia symptoms using the NOMAS and a VFSS.\n\n          -  Infants with intraventricular hemorrhage (IVH) and hypoxic events can be included.\n\n          -  Infants taking less than 5-10% of target volume by mouth between the ages of 36-42\n             weeks PCA.\n\n          -  Multiple swallows to clear bolus following suck that includes a desaturation <80% and\n             bradycardia <80 bpm.\n\n          -  Apnea spells during feeds.\n\n          -  Aspiration or penetration by VFSS\n\n        Exclusion Criteria:\n\n          -  Known neurologic or neurodegenerative disorders.\n\n          -  Chromosomal anomalies and syndromes.\n\n          -  Cleft lip or palate.\n\n          -  Birth defects.\n\n          -  Unresolved cutaneous rash at the area of electrode placement.\n\n          -  Medical condition that is a contraindication to NMES."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "42 Weeks", 
            "minimum_age": "36 Weeks"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02007759", 
            "org_study_id": "SH NMES for Dysphagia"
        }, 
        "intervention": [
            {
                "arm_group_label": "VitalStim", 
                "description": "This group will receive active VitalStim treatment.", 
                "intervention_name": "VitalStim", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Sham VitalStim", 
                "description": "This group will receive a sham VitalStim intervention.", 
                "intervention_name": "Sham VitalStim", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Dysphagia", 
            "neuromuscular electrical stimulation", 
            "NMES", 
            "Neonates", 
            "Vitalstim"
        ], 
        "lastchanged_date": "December 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Sioux Falls", 
                    "country": "United States", 
                    "state": "South Dakota", 
                    "zip": "57117"
                }, 
                "name": "Sanford USD Medical Center"
            }, 
            "investigator": {
                "last_name": "Akram Khan, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Treatment of Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates", 
        "overall_contact": {
            "email": "jeremy.morgan@sanfordhealth.org", 
            "last_name": "Jeremy P Morgan, MS", 
            "phone": "605-328-1398"
        }, 
        "overall_contact_backup": {
            "email": "diane.hahn@sanfordhealth.org", 
            "last_name": "Diane Hahn", 
            "phone": "605-328-1361"
        }, 
        "overall_official": {
            "affiliation": "Sanford Health", 
            "last_name": "Akram Khan, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Reduction in G-tube rate insertions for the treatment grouped compared to the sham group.", 
                "safety_issue": "No", 
                "time_frame": "Over the course of the treatment time frame to discharge, 2 weeks to 8 weeks"
            }, 
            {
                "measure": "Increased percent of subjects towards achieving full oral feedings earlier in the subject's dysphagia treatment.", 
                "safety_issue": "No", 
                "time_frame": "Over the course of the treatment time frame to discharge, 2 weeks to 8 weeks"
            }, 
            {
                "measure": "Increase the amount of formula volume taken at feedings from beginning to end of study.", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }, 
            {
                "measure": "Earlier NG tube removal for the treatment group compared to the control group.", 
                "safety_issue": "No", 
                "time_frame": "Over the course of the treatment time frame to discharge, 2 weeks to 8 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02007759"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sanford Health", 
            "investigator_full_name": "M. Akram Khan", 
            "investigator_title": "Neonatologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Improve swallowing skills as measured by videofluoroscopic swallowing study (VFSS) and the video swallow assessment worksheet.", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }, 
            {
                "measure": "Decrease spells with oral feeds over the course of the study.", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }, 
            {
                "measure": "Allow for healthy weight gain via improved feedings.", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }, 
            {
                "measure": "Increase the caloric intake orally.", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }, 
            {
                "measure": "Decrease the oxygen requirement before and after study.", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }, 
            {
                "measure": "Decrease inpatient length of stay.", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }
        ], 
        "source": "Sanford Health", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sanford Health", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}